Evidence map›Paper›PMID 35573730›Full record

ArticleFrontiers in molecular biosciences2022

Corrigendum: Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides.

Maria Carmina Scala, Simone Di Micco, Delia Lanzillotta, Simona Musella, Veronica Di Sarno, Barbara Parrino, Stella Maria Cascioferro, Giuseppe Bifulco, Francesco Trapasso, Pietro Campiglia and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular biosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Maria Carmina ScalaDepartment of Pharmacy, University of Salerno, Fisciano, Italy.
Simone Di MiccoEuropean Biomedical Research Institute of Salerno (EBRIS), Salerno, Italy.
Delia LanzillottaDepartment of Experimental and Clinical Medicine, University Magna Græcia, Campus S. Venuta, Catanzaro, Italy.
Simona MusellaEuropean Biomedical Research Institute of Salerno (EBRIS), Salerno, Italy.
Veronica Di SarnoDepartment of Pharmacy, University of Salerno, Fisciano, Italy.
Barbara ParrinoDepartment of Biological Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy.
Stella Maria CascioferroDepartment of Biological Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy.
Giuseppe BifulcoDepartment of Pharmacy, University of Salerno, Fisciano, Italy.
Francesco TrapassoDepartment of Experimental and Clinical Medicine, University Magna Græcia, Campus S. Venuta, Catanzaro, Italy.
Pietro CampigliaDepartment of Pharmacy, University of Salerno, Fisciano, Italy.
Marina SalaDepartment of Pharmacy, University of Salerno, Fisciano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fmolb.2021.715263.].

Indexed as

annexin A4biophysical assaychemoresistanceFHITpeptide

Identifiers

PMID35573730
PMCPMC9099253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.